DX
Last reporting period 31 Dec, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.148
Exchange
XLON - London Stock Exchange
0.0006 B
Last period CFO ,GBP
308%
CFO has increased in 4 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Diaceutics
Company Analysis
DXRX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
DXRX.L financial analysis by Eyestock methodology
Valuation
DXRX.L valuation using historical relative method
Statements
DXRX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
DXRX.L dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Diaceutics`s CFO for the period ended 2023-12-31 is 0.0006 B GBP
